Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cipla Medpro South Africa Ltd Updates On Scheme Of Arrangement With Cipla Limited


Friday, 28 Jun 2013 03:12am EDT 

Cipla Medpro South Africa Ltd announced that with reference to the previous announcement, regarding the approval at the general meeting of Cipla Medpro, by the requisite majority of shareholder votes, of the scheme of arrangement proposed by the board of directors of Cipla Medpro between Cipla Medpro and shareholders, in respect of the acquisition by Cipla India of 100% of the issued ordinary shares of Cipla Medpro (the Scheme). Shareholders are hereby advised that all conditions precedent to the Scheme, as detailed in the Circular issued to Cipla Medpro shareholders on April 15, 2013 (the Circular), have been fulfilled or waived (a TRP compliance certificate having been received on June 27, 2013), and accordingly, the Scheme has become unconditional, as of June 27, 2013. In terms of the Scheme, each Cipla Medpro shareholder is entitled to receive a cash consideration of ZAR10.00 for every Cipla Medpro share held. 

Company Quote

617.6
-7.5 -1.20%
19 Dec 2014